Cardiome Pharma News | finanzen.ch

Kurse + Charts + Realtime	News + Analysen	Fundamental	Unternehmen	zugeh. Wertpapiere	Aktion
Kurs + Chart	Chart (gross)	News + Adhoc	Bilanz/GuV	Termine	Strukturierte Produkte	Portfolio
Times + Sales	Chartvergleich	Analysen	Schätzungen	Profil		Watchlist
Börsenplätze	Realtime Push	Kursziele	Dividende/GV
Historisch			Analysen

Kurse + Charts + Realtime

News + Analysen

Fundamental

Unternehmen

zugeh. Wertpapiere

Aktion

Kurs + Chart

Chart (gross)

News + Adhoc

Bilanz/GuV

Termine

Strukturierte Produkte

Portfolio

Times + Sales

Chartvergleich

Analysen

Schätzungen

Profil

Watchlist

Börsenplätze

Realtime Push

Kursziele

Dividende/GV

Historisch

Analysen

13.03.18	CannTrust(MD) Holdings Inc. étend sa présence sur le marché international par la formation d'une coentreprise au Danemark avec STENOCARE (PR Newswire)
07.03.18	IIROC Trading Resumption - AXIS (PR Newswire)
23.01.18	Republic Live, producteur du festival de musique Boots and Hearts, embauche une acheteuse de spectacles à l'interne (PR Newswire)
30.11.17	Les Grands Prix santé et sécurité du travail de la CNESST - La CNESST est à la recherche de Leaders en santé et sécurité du travail (PR Newswire)
15.11.17	Home Capital Reports Third Quarter 2017 Results (PR Newswire)
08.11.17	Crombie REIT Reports Third Quarter 2017 Results (PR Newswire)
05.11.17	Amy Millar Claims First Canadian Show Jumping Championship Title at Toronto's Royal Horse Show (PR Newswire)
27.10.17	Norbord Reports Third Quarter 2017 Results; Increases Quarterly Dividend (PR Newswire)
24.10.17	/R E P R I S E -- Avis aux médias - Emploi et Développement social Canada/ (PR Newswire)
23.10.17	Canadian Broker Network announces the 2017 Underwriter Awards (PR Newswire)
09.10.17	/R E P R I S E -- Avis au public - Pont levant du canal de Burlington - Fermetures de nuit/ (PR Newswire)
02.10.17	iA Clarington launches global and emerging market funds for income-seeking investors (PR Newswire)
20.12.16	Cardiome Announces Commercial Launch of XYDALBA™ (dalbavancin) in Germany (PR Newswire)
08.12.16	Cardiome Announces Commercial Launch of Xydalba™ (dalbavancin) in the UK (PR Newswire)
29.11.16	Cardiome Advances Toward the UK XYDALBA™ (dalbavancin) Launch (PR Newswire)
19.11.13	CRME Opens Wallet, CGIX Launches FHACT, ENTA's SAPPHIRE Sparkles, IPCI Explodes (RTTNews)
21.10.13	Cardiome Enters Commercialization Agreement With Algorithm S.A.L. For BRINAVESS™ In Middle East And North Africa (PR Newswire)
10.10.13	TO2015 félicite l'olympien Curt Harnett qui vient d'être nommé chef de mission d'Équipe Canada pour les Jeux panaméricains de 2015 à Toronto (PR Newswire)
09.10.13	Cardiome Announces Commercialization Agreement With Biospifar S.A. For BRINAVESS™ In Colombia (PR Newswire)
07.10.13	Cardiome gibt Veröffentlichung der positiven Daten einer retrospektiven Beobachtungsstudie von BRINAVESS bekannt (PR Newswire)
07.10.13	Cardiome annonce la publication de données positives d'après une étude rétrospective par observation du produit BRINAVESS (PR Newswire)
07.10.13	Cardiome Announces Positive Data From BRINAVESS Study - Quick Facts (RTTNews)
07.10.13	Cardiome Announces Publication of Positive Data from an Observational, Retrospective Study of BRINAVESS (PR Newswire)
07.10.13	Cardiome Announces Publication of Positive Data from an Observational, Retrospective Study of BRINAVESS (PR Newswire)
01.10.13	ACRX Files Zalviso NDA, BGMD Gets A Booster, UK's NICE Turns Nice To PSDV (RTTNews)
30.09.13	Cardiome Pharma Gets Approval For BRINAVESS In South Africa - Quick Facts (RTTNews)
30.09.13	Cardiome Receives Approval For BRINAVESS™ In South Africa (PR Newswire)
25.09.13	Cardiome erhält Zulassung für BRINAVESS™ in der Türkei (PR Newswire)
25.09.13	Cardiome obtient l'homologation de BRINAVESS™ en Turquie (PR Newswire)
25.09.13	Cardiome Receives Approval For BRINAVESS™ In Turkey (PR Newswire)
25.09.13	Cardiome Receives Approval for BRINAVESS™ in Turkey (PR Newswire)
24.09.13	Cardiome Announces Commercialization Partnership with LifePharma (Z.A.M) Ltd. for BRINAVESS™ in Cyprus (PR Newswire)
24.09.13	Cardiome Announces Commercialization Partnership with LifePharma (Z.A.M) Ltd. for BRINAVESS™ in Cyprus (PR Newswire)
24.09.13	Cardiome annonce la publication de données positives à l'issue d'un essai clinique comparant le vernakalant IV à la propafénone et à la flécaïnide (PR Newswire)
24.09.13	Cardiome meldet Veröffentlichung positiver Ergebnisse aus Vergleichsstudie von Vernakalant IV mit Propafenon und Flecainid (PR Newswire)
23.09.13	Cardiome: Positive Data From Comparing Vernakalant Vs Propafenone And Flecainide (RTTNews)
23.09.13	Cardiome Announces Publication Of Positive Data From A Study Comparing Vernakalant IV Versus Propafenone And Flecainide (PR Newswire)
23.09.13	Cardiome Announces Publication Of Positive Data From A Study Comparing Vernakalant IV Versus Propafenone And Flecainide (PR Newswire)
23.09.13	Cardiome Announces Publication of Positive Data from a Study Comparing Vernakalant IV Versus Propafenone and Flecainide (PR Newswire)
17.09.13	Cardiome Announces Commercialization Agreement With Tzamal Medical Group For BRINAVESS™ In Israel (PR Newswire)
17.09.13	Cardiome Announces Commercialization Agreement With Tzamal Medical Group For Brinavess™ In Israel (PR Newswire)
17.09.13	Cardiome schliesst Verantwortungsübergabe für die Vermarktung von Brinavess™ in der EU ab (PR Newswire)
17.09.13	Cardiome termine le transfert de la responsabilité de commercialisation de Brinavess™ dans l'Union européenne (PR Newswire)
16.09.13	Cardiome Completes Transfer of Commercialization Responsibility For Brinavess™ in the EU (PR Newswire)
16.09.13	Cardiome Completes Transfer Of Commercialization Responsibility For Brinavess™ In The EU (PR Newswire)
30.08.13	Cardiome kündigt Anwesenheit auf dem ESC Congress 2013 in Amsterdam an (PR Newswire)

Aktien Top/Flop

SMI
SPI
SLI
SMIM
DAX
ESTOXX
Dow Jones
S&P 500
NASDAQ 100
Nikkei 225

Kuehne+Nagel Int	211.50	0.52 %	K V
Novartis	96.59	0.44 %	K V
Nestle	82.50	0.15 %	K V
Roche Hldg G	294.70	-0.07 %	K V
Logitech Intl	93.82	-0.34 %	K V
Sika	234.60	-2.13 %	K V
Part Grp Hldg	1’384.00	-2.16 %	K V
Geberit	522.60	-2.21 %	K V
Swiss Re	139.15	-2.45 %	K V
Holcim	95.48	-4.39 %	K V

mehr

Portfolioname Watchlistname
Portfolio
Name
Typ
Valor / ISIN
Börse
Anzahl
Aktueller Kurs
Kurszeit
Kaufpreis
Kaufdatum
Kaufwert	CHF
	Hinzufügen Speichern

Nachrichten zu Cardiome Pharma Corp.

Aktien Top/Flop

Meistgelesene Nachrichten